B.A. Morse et al. Screening iPSC lines for optimal characteristics of differentiation into immune effector cells for clinical programs. Cancer Res (2024) 84 (6_Supplement): 3613. 

https://www.centurytx.com/wp-content/uploads/AACR-2024-Poster-3613-4.8.pdf 

CY Kao, J.A. Mills, C.J. Burke, B.A. Morse, B.F. Marques.  Role of Cytokines and Growth Factors in the Manufacturing of iPSC-Derived Allogeneic Cell Therapy Products.  Biology ((2023 12(5), 677)) 

https://pubmed.ncbi.nlm.nih.gov/37237491/ 

Strohl, W. R., Naso, M.  Bispecific T-Cell Redirection versus Chimeric Antigen Receptor (CAR)-T Cells as Approaches to Kill Cancer Cells.  Antibodies, 2019, 8, 41.   

https://pubmed.ncbi.nlm.nih.gov/31544847/ 

Naso, M. F., Tomkowicz, B., Perry, W. L. III, and Strohl, W. R.  Adeno-Associated Virus (AAV) as a Vector for Gene Therapy.  BioDrugs, August 2017, 31, 317-334. 

https://pubmed.ncbi.nlm.nih.gov/28669112/  

Naso, MF, Lu, J, Panavas, T.  Deep Sequencing Approaches to Antibody Discovery. Current Drug Discovery Technologies. 2014, 11, 85-95. 

 https://pubmed.ncbi.nlm.nih.gov/24020911/ 

B.A. Morse et al. CXCR4 transgene improves in vivo migration and efficacy of engineered iPSC-derived natural killer cells. Cancer Res (2024) 84 (6_Supplement): 6802. 

https://www.centurytx.com/wp-content/uploads/AACR-2024-6802-4.10.pdf 

Naso, MF., Tam, S, Scallon, B, Raju, S.  Engineering Host Cell Lines to Reduce Terminal Sialylation of Secreted Antibodies.  Mabs., 2010:519-527.

https://pubmed.ncbi.nlm.nih.gov/20716959/

Scallon, B, McCarthy, S, Radewonuk, J, Cai, A, Naso, M, Raju, TS, and Capocasale, R.  Quantitative Comparisons In Mice Of An Fc-Dependent Agonist Activity Induced By Fc Fucosylation Variants Of An Immunoglobulin G Antibody.  Inter. Immunopharm.  2007, 7:761-772.

https://pubmed.ncbi.nlm.nih.gov/17466910/

Scallon B, Cai A, Armstrong J, and Naso M.  Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency.  Mol Immunol..  2004  May;  41(1):73-80.

https://pmc.ncbi.nlm.nih.gov/articles/PMC10755875/

J.M. Carton 1, T Sauerwald, P Hawley-Nelson, B.A. Morse, N Peffer, H Beck, J Lu, A Cotty, B Amegadzie, R Sweet.   Codon engineering for improved antibody expression in mammalian cells.  Protein Expression and Purification (2007), 55(2):279-86 

https://www.sciencedirect.com/science/article/abs/pii/S1046592807001477?via%3Dihub